Pataday Extra Strength Once Daily Relief®
olopatadine 0.7% · ophthalmic solution
Allergy
Approved uses
Itchy eyes due to pollen, ragweed, grass, animal hair and dander
1 drop in each affected eye QD
Itch relief from a single drop still holds at 24 hours, outlasting the 0.2% and 0.1% strengths.
OFF-LABELNot in the FDA label for this product
Conjunctival redness of allergic conjunctivitis
1 drop in each eye QD, the labeled regimen; the trial gave a single drop before each challenge
RCT · n=202 · CAC model
Phase 3 multicenter double-masked randomized CAC trial (N=202) of a single drop against vehicle and against olopatadine 0.2%: conjunctival redness scores were lower than vehicle at onset of action (P<0.001) and at the 16-hour (P<0.01) and 24-hour (P<0.05) challenges, and lower than olopatadine 0.2% at 24 hours (P<0.05). The OTC Use statement claims relief of itch only, so redness is an unlabeled endpoint.
Contraindications
- Do not use if solution changes color or becomes cloudy
- Do not use if you are sensitive to any ingredient in this product
- Do not use to treat contact lens related irritation
Ophthalmic solution, 0.5 mL bottle, 2.5 mL bottle, two bottle and three bottle 2.5 mL cartons, 0.7% (7 mg/mL)
Selective histamine H1 receptor antagonist that also stabilizes mast cells, cutting both the response to histamine already released and further degranulation. Human mast cell culture shows reduced histamine and TNF-alpha release, and conjunctival allergen challenge shows lower tear histamine.
Warnings & Precautions
- For external use only: Only for use in the eye.
- When using this product: Do not touch tip of container to any surface to avoid contamination. Remove contact lenses before use, wait at least 10 minutes before reinserting contact lenses after use, and do not wear a contact lens if your eye is red.
- Stop use and ask a doctor: Stop use and ask a doctor if you experience eye pain, changes in vision, increased redness of the eye, or itching that worsens or lasts for more than 72 hours.
- Keep out of reach of children: If swallowed, get medical help or contact a Poison Control Center right away.
Common Side Effects
- Ocular: Blurred vision, the most frequent ocular treatment-emergent event in a 6-week randomized vehicle-controlled safety study, 4.8% versus 4.1% on vehicle.
- Overall tolerability: Treatment-emergent adverse events in 26.7% of treated subjects versus 31.4% on vehicle in that study, with no deaths and no serious adverse events.
Pregnancy: No data in this OTC label.
Lactation: No data in this OTC label.
Labeled for ages 2 and older.